Trials / Completed
CompletedNCT05831267
Fibrin Glue Versus Titanium Platelet-rich Fibrin in Lateral Sinus Lifting
Fibrin Glue Versus Titanium Platelet-rich Fibrin as a Sole Filling Material in Lateral Sinus Lifting With Simultaneous Implant Placement (Randomized Controlled Clinical Trial )
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hams Hamed Abdelrahman · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Graftless sinus lift with simultaneous implant placement is one of the new techniques, this new technique is presented based on the physiology of intrasinus bone repair. Schneiderian membrane is known to have an osteogenic nature, now blood clot can be considered autologous osteogenic graft material, to which osteoprogenitors can migrate, differentiate, and regenerate bone. The aim of this study is to evaluate the effectiveness of using Fibrin glue versus Titanium platelet rich fibrin (T-PRF) as a sole filling material in lateral sinus lifting using with simultaneous implant placement in comparison to a negative control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fibrin Glue | Blood samples were collected from the antecubital vein of the right or left arm of the patient and drawn into sterile Titanium tubes immediately. The tubes were then centrifuged for 12 minutes at 2800 rpm and room temperature |
| OTHER | T-PRF | The contents of the two containers (human fibrinogen, human thrombin) will be mixed with distilled water and then aspirated by two syringes after that, the two solutions will be mixed together and injected into the empty compartment around the dental implant under the sinus mucosal lining using auto mixing applicator. |
| OTHER | Negative control | this group will not receive any material. |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2022-09-30
- Completion
- 2022-09-30
- First posted
- 2023-04-26
- Last updated
- 2023-04-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05831267. Inclusion in this directory is not an endorsement.